首页> 外文期刊>International Journal of Pharmaceutics >Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery.
【24h】

Development and evaluation of penciclovir-loaded solid lipid nanoparticles for topical delivery.

机译:开发和评估喷昔洛韦的固体脂质纳米粒用于局部递送。

获取原文
获取原文并翻译 | 示例
       

摘要

The objective of this investigation was to develop solid lipid nanoparticles (SLNs) of penciclovir and evaluate the potential of SLNs as the carrier of penciclovir for topical delivery. Penciclovir-loaded SLNs were prepared by a double (W/O/W) emulsion technique. The SLNs presented spherical with the mean diameter of 254.9 nm. The entrapment efficiency, drug loading and zeta potential were 92.40%, 4.62% and -25.0 mV, respectively. DSC study showed that penciclovir encapsulated in SLNs was in the amorphous form. The cumulative amount of penciclovir penetrated through excised rat skin from SLNs was more than 2-fold that of the commercial cream as a control at 12h after administration. There was no significant difference of penciclovir content deposited in epidermis between the cream and SLNs administrated for 2, 6 and 12h, while SLNs increased the cumulative uptake of penciclovir in dermis significantly at the same intervals. Microscopic pictures showed that the interaction between SLNs and the skin surface changed the apparent morphology of stratum corneum and broke the close conjugation of corneocyte layers, which was the possible reason that SLNs increased the permeation of penciclovir into skin dermis. It can be concluded from our study that SLNs provide a good skin targeting effect and may be a promising carrier for topical delivery of penciclovir.
机译:这项研究的目的是开发喷昔洛韦的固体脂质纳米颗粒(SLN),并评估SLN作为喷昔洛韦局部给药载体的潜力。通过双(W / O / W)乳液技术制备了喷昔洛韦负载的SLN。 SLN呈球形,平均直径为254.9 nm。包封率,载药量和ζ电位分别为92.40%,4.62%和-25.0 mV。 DSC研究表明,包裹在SLNs中的喷昔洛韦为无定形形式。在给药后12h,从SLNs穿刺的大鼠皮肤渗透的喷昔洛韦的累积量是市售乳膏的2倍,是对照组的2倍。乳膏和SLNs分别在2、6和12h施用后,沉积在表皮中的喷昔洛韦含量没有显着差异,而SLNs在相同的间隔显着增加了真皮中喷昔洛韦的累积吸收。显微照片显示,SLNs与皮肤表面的相互作用改变了角质层的表观形态,破坏了角质层的紧密结合,这可能是SLNs增加了喷昔洛韦向皮肤真皮渗透的原因。从我们的研究可以得出结论,SLNs具有良好的皮肤靶向作用,并且可能是喷昔洛韦局部给药的有希望的载体。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号